Eterna Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1 | $487 |
Gross Profit | -55 | -69 | 542 | 547 |
EBITDA | -2,501 | -2,661 | -2,197 | -24,455 |
EBIT | -2,556 | -2,730 | -2,265 | -24,906 |
Net Income | -3,147 | -8,202 | -5,759 | -26,604 |
Net Change In Cash | 0 | 0 | 1 | 487 |
Free Cash Flow | -2,532 | -2,065 | -3,545 | -6,304 |
Cash | 4,315 | 1,918 | 1,729 | 4,264 |
Basic Shares | 5,179 | 53,361 | 51,386 | 5,410 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $582 | $68 | $0 | $0 |
Gross Profit | 486 | -168 | -497 | -459 |
EBITDA | -36,119 | -19,934 | -24,007 | -121,948 |
EBIT | -37,757 | -21,057 | -24,504 | -122,407 |
Net Income | -44,539 | -21,668 | -24,579 | -122,306 |
Net Change In Cash | 582 | 68 | 0 | 0 |
Free Cash Flow | -16,205 | -20,427 | -21,273 | -23,642 |
Cash | 1,729 | 7,575 | 11,446 | 16,985 |
Basic Shares | 28,398 | 5,314 | 3,051 | 2,165 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.61 |
2025-03-31 | -$2.31 |
2024-12-31 | -$0.15 |
2023-09-30 | -$1.03 |
